REQUEST A DEMO
Total
USD $0.00
Search more companies

Biolife Lab Sdn. Bhd. (Malaysia)

Main Activities: Ambulatory Health Care Services
Full name: Biolife Lab Sdn. Bhd. Profile Updated: August 31, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Biolife Lab Sdn. Bhd. is an enterprise in Malaysia, with the main office in Kuala Lumpur. It operates in the Ambulatory Health Care Services industry. The company was established on March 25, 2005. From the latest financial highlights, Biolife Lab Sdn. Bhd. reported a net sales revenue drop of 43.58% in 2022. Its total assets grew by 2.13% over the same period. The net profit margin of Biolife Lab Sdn. Bhd. decreased by 8.82% in 2022.

Headquarters
Wisma Life Centre, 1St Floor, 5 Jalan Kerinchi, Bangsar South
Kuala Lumpur; Federal Territories; Postal Code: 59200

Contact Details: Purchase the Biolife Lab Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Biolife Lab Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Biolife Lab Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Biolife Lab Sdn. Bhd. report to view the information.
Incorporation Date:
March 25, 2005
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Biolife Lab (Sibu) Sdn. Bhd.
55%
Company Performance
Financial values in the chart are available after Biolife Lab Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
-43.58%
Total operating revenue
-43.58%
Operating profit (EBIT)
-63.3%
EBITDA
-60.68%
Net Profit (Loss) for the Period
-63.77%
Total assets
2.13%
Total equity
7.9%
Operating Profit Margin (ROS)
-11.49%
Net Profit Margin
-8.82%
Return on Equity (ROE)
-14.48%
Debt to Equity Ratio
-2.85%
Quick Ratio
2.57%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?